150 related articles for article (PubMed ID: 9436780)
1. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of class-III antiarrhythmic drugs: chromanol 293B, but not dofetilide blocks the smooth muscle delayed rectifier K+ channel.
Karle CA; Bauer A; Weretka S; Zitron E; Abushi A; Kreye VA; Schoels W
Basic Res Cardiol; 2002 Jan; 97(1):17-25. PubMed ID: 11998973
[TBL] [Abstract][Full Text] [Related]
3. Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies.
Gjini V; Korth M; Schreieck J; Weyerbrock S; Schömig A; Schmitt C
J Cardiovasc Pharmacol; 1996 Aug; 28(2):314-20. PubMed ID: 8856489
[TBL] [Abstract][Full Text] [Related]
4. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes.
Bosch RF; Gaspo R; Busch AE; Lang HJ; Li GR; Nattel S
Cardiovasc Res; 1998 May; 38(2):441-50. PubMed ID: 9709405
[TBL] [Abstract][Full Text] [Related]
5. Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium.
Weyerbrock S; Schreieck J; Karch M; Overbeck M; Meisner H; Kemkes B; Schömig A; Schmitt C
J Cardiovasc Pharmacol; 1997 Nov; 30(5):571-5. PubMed ID: 9388038
[TBL] [Abstract][Full Text] [Related]
6. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
[TBL] [Abstract][Full Text] [Related]
7. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
Mehdirad AA; Carnes CA; Nelson SD
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender.
Abi-Gerges N; Small BG; Lawrence CL; Hammond TG; Valentin JP; Pollard CE
Br J Pharmacol; 2006 Mar; 147(6):653-60. PubMed ID: 16314855
[TBL] [Abstract][Full Text] [Related]
10. Both beta-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of I(Ks) channel blockers in vitro.
Lu HR; Vlaminckx E; Van De Water A; Gallacher DJ
J Pharmacol Toxicol Methods; 2005; 51(2):81-90. PubMed ID: 15767201
[TBL] [Abstract][Full Text] [Related]
11. Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart.
Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Hansen A; Müller M; Lang HJ; Gerlach U; Busch A; Kraft P; Kübler W; Schöls W
Circulation; 1999 Nov; 100(21):2184-90. PubMed ID: 10571978
[TBL] [Abstract][Full Text] [Related]
12. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
Zhang ZH; Follmer CH; Sarma JS; Chen F; Singh BN
J Pharmacol Exp Ther; 1992 Oct; 263(1):40-8. PubMed ID: 1403801
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model.
Yang Z; Shi G; Li C; Wang H; Liu K; Liu Y
J Cardiovasc Electrophysiol; 2004 Jul; 15(7):815-20. PubMed ID: 15250869
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
Baláti B; Iost N; Simon J; Varró A; Papp JG
Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
[TBL] [Abstract][Full Text] [Related]
15. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
Cheng HC; Incardona J
J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
[TBL] [Abstract][Full Text] [Related]
16. Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.
Lynch JJ; Baskin EP; Nutt EM; Guinosso PJ; Hamill T; Salata JJ; Woods CM
J Cardiovasc Pharmacol; 1995 Feb; 25(2):336-40. PubMed ID: 7752661
[TBL] [Abstract][Full Text] [Related]
17. Blocking action of chromanol 293B on the slow component of delayed rectifier K(+) current in guinea-pig sino-atrial node cells.
Ding WG; Toyoda F; Matsuura H
Br J Pharmacol; 2002 Sep; 137(2):253-62. PubMed ID: 12208783
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes.
Kiehn J; Villena P; Beyer T; Brachmann J
J Cardiovasc Pharmacol; 1994 Oct; 24(4):566-72. PubMed ID: 7528839
[TBL] [Abstract][Full Text] [Related]
19. Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium.
Bosch RF; Milek IV; Popovic K; Mermi J; Mewis C; Kühlkamp V; Seipel L
J Cardiovasc Pharmacol; 1999 May; 33(5):762-71. PubMed ID: 10226864
[TBL] [Abstract][Full Text] [Related]
20. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
